Literature DB >> 9379193

Three-dimensional imaging of cortical structure, function and glioma for tumor resection.

T Nariai1, M Senda, K Ishii, T Maehara, S Wakabayashi, H Toyama, K Ishiwata, K Hirakawa.   

Abstract

UNLABELLED: A three-dimensional brain imaging protocol with PET and MRI was used to visualize the cortical structure in relation to brain function and glioma infiltration to determine tumor resectability.
METHODS: Sixteen patients with glioma had a PET scan with 11C-methionine to visualize tumor infiltration. The PET images were co-registered to the patients' own MRI reconstructed to the three-dimensional brain surface images to indicate the gyral structure and the extent of tumor infiltration. Thirteen patients, who bore tumors adjacent to the language or motor cortex, had H2 15O activation study to locate the eloquent cortex. The area of tumor infiltration was superimposed on the brain surface images together with the language and/or motor cortex.
RESULTS: When a tumor was located within a single gyrus without influencing surface cortical gyrus pattern, the motor and language areas were identified morphologically by three-dimensional surface image alone. However, when the tumor caused swelling and deformation of cortical structure, functional mapping with H2(15)O activation technique was essential in locating them correctly. In such cases, the combined mapping of the facial motor area with oral movement and the language area with word repetition was the most useful method to identify the parasylvian structure in the dominant hemisphere. Total or near total resection of low-grade glioma in eight patients and the effective decompression of the active part of the malignant glioma in four patients was completed without causing functional neurological deterioration.
CONCLUSION: The three-dimensional expression of cortical structure and function combined with PET glioma imaging with 11C-methionine is useful for radical resection of cerebral glioma.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9379193

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  7 in total

1.  Tracking tumor growth rates in patients with malignant gliomas: a test of two algorithms.

Authors:  S M Haney; P M Thompson; T F Cloughesy; J R Alger; A W Toga
Journal:  AJNR Am J Neuroradiol       Date:  2001-01       Impact factor: 3.825

2.  Three-dimensional integration of brain anatomy and function to facilitate intraoperative navigation around the sensorimotor strip.

Authors:  J P Mäkelä; E Kirveskari; M Seppä; M Hämäläinen; N Forss; S Avikainen; O Salonen; S Salenius; T Kovala; T Randell; J Jääskeläinen; R Hari
Journal:  Hum Brain Mapp       Date:  2001-03       Impact factor: 5.038

Review 3.  Imaging in neurooncology.

Authors:  Andreas H Jacobs; Lutz W Kracht; Axel Gossmann; Maria A Rüger; Anne V Thomas; Alexander Thiel; Karl Herholz
Journal:  NeuroRx       Date:  2005-04

Review 4.  11C-L-methionine positron emission tomography in the clinical management of cerebral gliomas.

Authors:  Tarun Singhal; Tanjore K Narayanan; Viney Jain; Jogeshwar Mukherjee; Joseph Mantil
Journal:  Mol Imaging Biol       Date:  2007-10-24       Impact factor: 3.488

5.  Contributions of biological tumor parameters to the incorporation rate of L: -[methyl-(11)C] methionine into astrocytomas and oligodendrogliomas.

Authors:  Takeko Nojiri; Tadashi Nariai; Masaru Aoyagi; Michio Senda; Kenji Ishii; Kiichi Ishiwata; Kikuo Ohno
Journal:  J Neurooncol       Date:  2008-12-20       Impact factor: 4.130

6.  Preoperative mapping of cortical language areas in adult brain tumour patients using PET and individual non-normalised SPM analyses.

Authors:  Philipp T Meyer; Laszlo Sturz; Mathias Schreckenberger; Uwe Spetzger; Georg F Meyer; Keyvan S Setani; Osama Sabri; Udalrich Buell
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-05-14       Impact factor: 9.236

Review 7.  Unconventional non-amino acidic PET radiotracers for molecular imaging in gliomas.

Authors:  Francesco Ceci; Andrei Iagaru; R Laudicella; N Quartuccio; G Argiroffi; P Alongi; L Baratto; E Califaretti; V Frantellizzi; G De Vincentis; A Del Sole; L Evangelista; S Baldari; S Bisdas
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-04-13       Impact factor: 10.057

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.